C153H130F3N29O12S — CID 160698984
N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-4-methyl-1,3-thiazole-5-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]pyridazine-3-carboxamide;2-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;3-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-4-carboxamide;1-[(4-methylphenyl)methyl]indazol-3-amine;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-5-carboxamide (PubChem CID 160698984) has the molecular formula C153H130F3N29O12S and a molecular weight of 2655.97 g/mol. Its IUPAC name is N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-4-methyl-1,3-thiazole-5-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]pyridazine-3-carboxamide;2-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;3-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-4-carboxamide;1-[(4-methylphenyl)methyl]indazol-3-amine;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-5-carboxamide.
| Compound Name | N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-4-methyl-1,3-thiazole-5-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]pyridazine-3-carboxamide;2-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;3-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-4-carboxamide;1-[(4-methylphenyl)methyl]indazol-3-amine;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-5-carboxamide |
|---|---|
| PubChem CID | 160698984 |
| Molecular Formula | C153H130F3N29O12S |
| Molecular Weight | 2655.97 g/mol |
| Exact Mass | 2654.01 |
| IUPAC Name | N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-2-methylfuran-3-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-4-methyl-1,3-thiazole-5-carboxamide;N-[1-[(4-fluorophenyl)methyl]indazol-3-yl]pyridazine-3-carboxamide;2-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;3-methyl-N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-4-carboxamide;1-[(4-methylphenyl)methyl]indazol-3-amine;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]furan-3-carboxamide;N-[1-[(4-methylphenyl)methyl]indazol-3-yl]-1,2-oxazole-5-carboxamide |
| SMILES | Cc1ccc(Cn2nc(N)c3ccccc32)cc1.Cc1ccc(Cn2nc(NC(=O)c3ccno3)c3ccccc32)cc1.Cc1ccc(Cn2nc(NC(=O)c3ccoc3)c3ccccc32)cc1.Cc1ccc(Cn2nc(NC(=O)c3ccoc3C)c3ccccc32)cc1.Cc1ccc(Cn2nc(NC(=O)c3conc3C)c3ccccc32)cc1.Cc1ncsc1C(=O)Nc1nn(Cc2ccc(F)cc2)c2ccccc12.Cc1occc1C(=O)Nc1nn(Cc2ccc(F)cc2)c2ccccc12.O=C(Nc1nn(Cc2ccc(F)cc2)c2ccccc12)c1cccnn1 |
| InChI | InChI=1S/C21H19N3O2.C20H16FN3O2.C20H18N4O2.C20H17N3O2.C19H14FN5O.C19H15FN4OS.C19H16N4O2.C15H15N3/c1-14-7-9-16(10-8-14)13-24-19-6-4-3-5-18(19)20(23-24)22-21(25)17-11-12-26-15(17)2;1-13-16(10-11-26-13)20(25)22-19-17-4-2-3-5-18(17)24(23-19)12-14-6-8-15(21)9-7-14;1-13-7-9-15(10-8-13)11-24-18-6-4-3-5-16(18)19(22-24)21-20(25)17-12-26-23-14(17)2;1-14-6-8-15(9-7-14)12-23-18-5-3-2-4-17(18)19(22-23)21-20(24)16-10-11-25-13-16;20-14-9-7-13(8-10-14)12-25-17-6-2-1-4-15(17)18(24-25)22-19(26)16-5-3-11-21-23-16;1-12-17(26-11-21-12)19(25)22-18-15-4-2-3-5-16(15)24(23-18)10-13-6-8-14(20)9-7-13;1-13-6-8-14(9-7-13)12-23-16-5-3-2-4-15(16)18(22-23)21-19(24)17-10-11-20-25-17;1-11-6-8-12(9-7-11)10-18-14-5-3-2-4-13(14)15(16)17-18/h3-12H,13H2,1-2H3,(H,22,23,25);2-11H,12H2,1H3,(H,22,23,25);3-10,12H,11H2,1-2H3,(H,21,22,25);2-11,13H,12H2,1H3,(H,21,22,24);1-11H,12H2,(H,22,24,26);2-9,11H,10H2,1H3,(H,22,23,25);2-11H,12H2,1H3,(H,21,22,24);2-9H,10H2,1H3,(H2,16,17) |
| InChIKey | RQJCMMRSEWUKBJ-UHFFFAOYSA-N |
| XLogP | 31.22 |
| TPSA | 502.43 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 198 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2655.97 |
| LogP ≤ 5 | 31.22 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 35 |